This is a multicenter prospective study that aims to investigate the clinical impact ofSARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.
This is a cohort study of pregnant women confirmed positive for SARS-CoV-2 infection.
Data will be collected in Portuguese maternities that agreed to collaborate in this
study.
Pregnant women are tested during hospital admission by using nasopharyngeal/oral swabs
for SARS-CoV-2 RT PCR as part of a universal testing policy. Maternal demographic data
(age, comorbidities, parity, smoking habits), COVID-19 related data (symptoms, diagnostic
tests, therapy used and ICU admission), gestational age at SARS-CoV-2 confirmed
infection, pregnancy outcomes (gestational complications, gestational age at birth, mode
of delivery) and neonatal outcome (birthweight and Apgar score, RT PCR neonate results)
and breastfeeding strategies will be evaluated.
Diagnostic Test: RT PCR SARS-CoV-2
Positive SARS-CoV-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood
samples
Other Name: SARS-COV-2 Serologic test
Inclusion Criteria: Pregnant women infected with Sars-Cov-2. Delivery at Portuguese
maternities.
Exclusion Criteria: RT PCR SARS-CoV-2 negative.
-
Nova Medical School - UNL
Lisbon, Portugal
Investigator: Nadia Charepe, MSc, MD
Contact: 00351213184000
nadia.charepe@chlc.min-saude.pt
Nadia Charepe, MD,MSc
00351213184000
nadia.charepe@chlc.min-saude.pt
Alexandra Queirós, MD
00351213184000
alexandra.queiros@nms.unl.pt